Background The androgen receptor (AR) is discussed as a prognostic and/or predictive
marker in breast cancer patients. Methods AR mRNA expression was analysed by RT-qPCR …

Introduction The androgen receptor (AR) is widely expressed in breast cancers and has
been proposed as a therapeutic target in estrogen receptor alpha (ER) negative breast …

Background: Breast cancer (BC) is associated with advanced presentation in developing
countries like India due to various socio-economic factors. The presence of BC molecular …

The androgen receptor (AR) is a ligand-dependent transcription factor, and its effects on
breast range from physiological pubertal development and age-related modifications to …

Abstract Background and aims Although Breast carcinoma had many targeted biomarkers
for its treatment, however, it is a heterogeneous disease with different outcomes and need …

Greater than 70% of human breast cancers express the androgen receptor (AR). Emerging
preclinical and clinical data suggest that AR may play a role in breast cancer pathogenesis …

The androgen receptor (AR) is a proven clinical target in prostate cancer. Recent research
indicates that it is an emerging hormonal target in breast cancer as well, with potential …

The androgen receptor (AR) is increasingly considered as a potential biomarker for breast
cancer. Nevertheless, the prognostic value of AR expression in patients with triple negative …

The Androgen Receptor (AR) is emerging as an important factor in the pathogenesis of
breast cancer (BC), which is the most common malignancy among females worldwide. The …

Androgen receptor (AR) is the most widely expressed steroid receptor protein in normal
breast tissue and is detectable in approximately 90% of primary breast cancers and 75% of …